Gómez i Prat, Jordi
Essadek, Hakima Ouaarab
Esperalba, Juliana
Serrat, Francesc Zarzuela
Guiu, Isabel Claveria
Goterris, Lidia
Zules-Oña, Ricardo
Choque, Estefa
Pastoret, Conxita
Ponces, Natàlia Casamitjana
de los Santos, Juan José
Pons, Jordi Serrano
Dehousse, Aurore
Albajar-Viñas, Pedro
Pumarola, Tomàs
Campins, Magda
Sulleiro, Elena
Funding for this research was provided by:
Fundación Mundo Sano
Article History
Received: 5 August 2021
Accepted: 17 March 2022
First Online: 28 March 2022
Declarations
:
: This study was carried out in accordance with relevant guidelines and ethical regulations. Vall d’Hebron Hospital Ethics Committee approved the study (PR(AG)371/2019). Prior to participating, all participants received oral information of the intervention prior and gave oral informed consent. For subjects under 16 and illiterate, parents or legal guardians gave oral consent to participate. Participants’ consent was registered in their computerized medical history. All those who consent were actively enrolled in the community action and underwent screening for Chagas disease and COVID-19. Oral consent was accepted by the Vall d’Hebron Hospital Ethics Committee as this intervention was included as regular clinical practice in our center and the intervention was not only performed for research purposes. Thus, this manuscript reports the results derived from regular clinical practice in our center. The screening procedures performed are the ones established and recommended by the WHO. Participants’ data were codified and analyzed anonymously. No data containing personal or identifying information from the participants have been published.
: Not applicable.
: The authors declare not having any potential conflict of interest to declare.